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ABSTRACT: Consumption of cruciferous vegetables (CVs) is inversely correlated to many human 
diseases including cancer (breast, lung, and bladder), diabetes, cardiovascular and neurological disease.  
Presently, there are no readily measureable biomarkers of CV consumption and intake of CVs has relied 
on dietary recall.  Here, biomarkers of CV intake were identified in the urine of 20 healthy Caucasian 
adult males using 
1
H-NMR spectroscopy with multivariate statistical modeling. The study was separated 
into three phases of 14 days:  a run-in period with restricted CV consumption (phase I); a high CV phase 
where participants consumed 250g/day of both broccoli and Brussels sprouts (phase II); a wash-out 
phase with a return to restricted CV consumption (phase III). Each study participant provided a complete 
cumulative urine collection over 48 hours at the end of each phase; a spot urine (U0), 0-10 hours (U0-
10), 10-24 hours (U10-24) and 24-48 hours (U24-48) urine samples. Urine samples obtained after 
consumption of CV were differentiated from low CV diet samples by 4 singlet 
1
H-NMR spectroscopic 
peaks, two of which were identified as S-methyl-L-cysteine sulphoxide (SMCSO) and N-acetyl-S-
methyl-L-cysteine sulphoxide (NAc-SMCSO). These stable urinary biomarkers of CV consumption will 
facilitate future assessment of CV in nutritional population screening and dietary intervention studies 
and may correlate to population health outcomes. 
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Introduction 
Epidemiological studies have consistently demonstrated an inverse association between cruciferous 
vegetable (CV) consumption and risk of cancer  
1, 2
 particularly lung 
3, 4
, stomach and neoplasms of the 
lower intestinal tract 
5
, bladder 
6
 and breast 
7
. Similarly, a protective effect has also been reported for 
cardiovascular disease
8
, diabetes
9
 and neurological disease
10
.  The family cruciferae is composed of 
foods of the species Brassica oleracea (cabbage, broccoli, cauliflower, Brussels sprouts, kale) and >350 
other genera. The chemoprotective power of CV against neoplastic disease is attributed to their abundant 
levels of glucosinolates (-thioglycoside-N-hydroxysulfates) in the human diet. Glucosinolates are 
hydrolysed by thioglucoside enzymes known as myrosinases which are released upon mastication of the 
plant material, this produces, dependent on reaction conditions, the biologically active isothiocyanates 
(ITC), indoles, nitriles and epithionitriles
11
.  
 
The ITCs are reported to form glutathione (GSH) conjugates and albumin adducts in vivo 
12, 13
. ITC-
GSH conjugates are known to be primarily excreted as ITC-mercapturates by the mercapturic acid 
pathway and have subsequently been used as urinary biomarkers of glucosinolate exposure
14
. However, 
the efficiency of the ITC mercapturates as measures of CV exposure is limited by a multitude of factors, 
such as abundance of the particular glucosinolates in the vegetable cultivar and species consumed, 
liberation and rate of formation from the plant material, cooking method, bioavailability, absorption 
from the digestive system, distribution around the body, endogenous metabolism and excretion
15
. 
Effective correlation between measurement of urinary ITC mercapturates and assessment of CV 
consumption is therefore reliant on many factors. Biomarkers of exposure, effect and susceptibility can 
potentially circumvent the difficulties associated with assessing the relationship between diet and 
detrimental/beneficial health outcomes and the efficacy of dietary interventions. Novel dietary 
biomarkers could also potentially provide further insights into the mechanisms of action of dietary 
components. 
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Metabolic profiling using high resolution spectroscopy, mainly nuclear magnetic resonance (NMR), or 
mass spectrometry with either liquid-chromatography (LC) or gas-chromatography technology, can be 
used to characterize the dynamic metabolic response of organisms to experimental interventions
16
. High 
resolution analytical platforms together with the aid of multivariate statistical modeling have been 
successfully applied to determine the metabolic response to a range of nutritional interventions in 
humans, for example, the effects of vegetarian and meat diets
17
 and recently by cluster analysis the 
identification of metabolic phenotypes associated with habitual dietary patterns; highlighting potentially 
robust biomarkers of meat and vegetable consumption
18
. Furthermore, metabolic phenotypic change has 
been reported attributable to soy isoflavone
19
, almond
20
, chamomile (Matricaria recutita L.)
21
, alcohol
22
, 
citrus fruit
23
, polyphenolics
24
 and green and black tea dietary interventions
25
. The use of metabonomic 
technologies for the identification of putative biomarkers of foodstuffs of significant public health 
interest has recently been reviewed by the Food Standards Agency (UK)
26
. It was concluded that it is 
possible to successfully identify potentially useful biomarkers of nutritional intervention utilising 
metabonomic methods. However, these putative biomarkers must be validated in population cohort 
studies and dietary surveys.  
 
Here we applied a metabolic profiling strategy using 
1
H-NMR spectroscopy and chemometric 
modeling to assess the changes in the human metabolic phenotype following nutritional intervention 
with CV intake over a two week period and have identified novel and robust urinary biomarkers of CV 
consumption. 
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Experimental Section 
Study protocol 
Twenty healthy male Caucasian subjects were recruited to a three period dietary intervention study 
that was controlled and planned by a clinical nutritionist
27
. Each of the three periods consisted of 14 
days duration. In phases I and III a low cruciferous vegetable diet was consumed for 12 days and for 
day’s 11-14 of each phase dietary restrictions were extended to pharmaceutical agents and foods such as 
alliums, which might confound dietary intervention analysis (Figure 1). Phase I was immediately 
followed by Phase II where subjects were maintained under supervision on a high cruciferous vegetable 
diet for 12 days. This consisted of a 250g/day of both broccoli and Brussels sprouts incorporated into a 
varying menu consumed under supervision at the BIBRA international clinical unit (Carshalton) at 
breakfast and dinner. Phase III, a return to the low CV diet immediately followed Phase II.  On day 13 of 
each phase, after an overnight fast, a time zero spot urine sample was obtained from each study 
participant. Participants were then maintained on a standardized diet and urine sample collections were 
obtained for the periods 0-10 hr, 10-24 hr and 24-48 hr. Therefore each subject provided 4 samples for 
each of the three dietary intervention periods. Urine samples were stored at -80˚C until required for 
analysis. 
 
Urine Sample Preparation  
A 1ml aliquot of each of the urine samples was taken for 
1
H-NMR spectroscopic analysis. To reduce 
pH induced chemical shift variability, a 400μl aliquot of urine sample was combined with 200 μl of 100 
mM phosphate buffer solution (pH 7.4), before centrifugation at 13,000 g av for 10 mins to remove 
particulate materials. Aliquots (500 μl) were transferred to a 96 deep-well plate in a randomized order 
with quality control samples (comprised of a pooled urine sample from 6 study participants) inserted 
every fifteenth sample and were mixed with 50μl of TSP/D2O solution (3-trimethylsilyl 2,2,3,3-
tetradeuteropropionate in deuterium oxide, 1 mM final concentration). TSP is an internal chemical shift 
reference (δ1H 0.0) and D2O provides a lock signal for the NMR spectrometer. The plates were covered 
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with adhesive film, mixed carefully and immediately prior to NMR analysis, were centrifuged at 3,000 g 
av for 5 mins.  
 
Flow Injection 600MHz 
1
H-NMR Spectroscopic analysis of Urine Samples 
NMR spectra were acquired in the stop-flow mode using a Bruker AMX600 spectrometer (operating 
at 600.13MHz 
1
H frequency at ambient probe temperature (298 ± 1 K)) with a 5mm single cell 
1
H/
13
C 
inverse detection flow probe with an active volume of 250μl. Sample transfer from the 96-well plate to 
the probe was automated by a Gilson (Middleton, WI, USA) XL233 sample-handling system interfaced 
to the XWinNMR data system for control and timing. For each sample, 450μl was aspirated from the 
well plate by sampling needle into the transfer line and separated from subsequent samples by 500μl of a 
push buffer containing HPLC grade water with 0.1% Sodium Azide (NaN3). The transfer time for each 
sample was approximately 180s to allow time for the sample to adjust to the probe temperature. Spectra 
were acquired, a standard one dimensional pulse sequence using the first increment of a NOE pulse 
sequence to suppress the large NMR signal of the solvent water
28
. For each sample 64 free induction 
decays were collected into 32768 time domain data points with a spectral width of 3140.7Hz, an 
acquisition time of 5.22s and a total recycle time of 6.22s. The FIDs were multiplied by a line-
broadening function of 1.0Hz to improve the signal–to-noise ratio prior to Fourier transformation, 
phasing and baseline correction.  
 
1
H-NMR Urine spectra pre-processing 
Full resolution spectra (δ10.0-0.24) were used for chemometric pattern recognition. Variation in the 
effect of pre-saturation of the water signal was removed by zeroing intensities in the region of the 
spectra δ 4.5-4.9. All spectra were referenced to the TSP internal standard reference (δ 0.0). Baseline 
correction of all of the spectra was achieved by polynomial curve fit (using a Matlab Version 7.0). 
Spline cubic interpolation was used to give all the spectra (42,000 data points) the same chemical shift. 
All urinary 
1
H-NMR spectra were spectrally aligned utilizing the recursive segment-wise peak 
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alignment (RSPA) algorithm
29
. To partially compensate for urine concentration differences between 
different samples all spectra were normalized using probabilistic quotient on full resolution data sets
30
. 
 
Principal Component Analysis of the 
1
H NMR Urine Spectra. 
In order to provide a data overview, explore intrinsic structure in the data and to identify any outlier 
samples, NMR spectral data were reduced to latent variables using principal components analysis 
(PCA)
31
.  
 
Partial Least Squares-Discriminant Analysis of the 
1
H NMR Urine Spectra. 
Partial Least Squares-Discriminant Analysis (PLS-DA), which models the maximum separation 
between defined class samples in the data using a dummy class variable as the Y data matrix, was used 
to optimize the extraction of candidate biomarkers. Subsequently, an orthogonal (O)-PLS-DA algorithm 
based on the method of orthogonal signal correction by Wold et. al 
32
 but incorporated directly into the 
PLS model
33
, was used to remove sources of systematic variation in the X matrix, unrelated to the class 
of interest (in this case cruciferous vegetable consumption).  The O-PLS-DA model is based on unit 
variance ‘uv’ scaled data, which is subsequently back-transformed by multiplying the O-PLS 
coefficients by their standard deviations. The O-PLS coefficients are colour coded according to 
correlation with class, the range of which are set to the maximum and minimum of the unit variance 
scaled model weight and gives an indication of the relative influence of an individual metabolite in class 
discrimination. 
 
Structural Identification of Candidate Biomarkers.  
Signals noted as being key discriminators of the high CV consumption class were identified using a 
combination of 2-dimensional NMR spectroscopy and statistical total correlation spectroscopy 
(STOCSY)
34
. The 2D J-resolved (J-RES) 
1
H homonuclear urinary spectrum was recorded using a 90° 
pulse of 8.9µs, 48 transients of 4096 complex points, 64 increments, relaxation delay of 2 s, and spectral 
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widths of 4 kHz in the 
1
H (f2) and 65 Hz in the J (f1) dimensions, respectively. 
1
H-
13
C 2D HSQC NMR 
spectra were recorded in echo-anti-echo mode using the gradient selection. The 
1
H and 
13
C spectral 
widths were 10.5 and 200 ppm respectively using a standard pulse sequence with recycle delay of 2 s. 
The δ-shifted sine bell window functions were applied for both dimensions before Fourier transforming 
into data with the standard Bruker linear-prediction. The delay for the 
1
H-
13
C 2D HMBC proton carbon 
long-range coupling was optimised for 10 Hz. For processing, a (π/2) squared sine bell window function 
in both dimensions was applied. Data comprising 4096 data points were processed in f2 and 2048 in f1, 
respectively.  
 
STOCSY driven from the key signals differentiating the CV class 2.83 (s) and 2.78 (s) was also 
used to extract further information regarding correlations between signals. Both 
1
H and
 13
C NMR 
assignments were made using online NMR database searches (eg. human metabolome database Hmdb, 
Genome Alberta), NMR prediction software (ACD labs) and published spectral data at neutral pH 
35, 36
. 
The candidate metabolites SMCSO and NAc-SMCSO were synthesised following previously published 
methods 
37-39
. The synthetic standards were subjected to 
1
H-NMR, 2D HSQC and HMBC analysis, and 
spiked into human urine in order to confirm identity.  
 
Biochemical Characterisation of Broccoli and Brussels Sprout Aqueous extractions 
1
H-NMR spectra of broccoli and Brussels sprouts were acquired to ascertain whether any of the 
discriminatory signals in the urine profiles of participants on the high CV diet directly originated from 
these vegetables. One ml of CH3CN:D2O (50:50; Acetonitrile:Deuterium Oxide) was combined with 
approximately 600mg of microwave cooked Brussels sprouts or broccoli and homogenised using a 
Quiagen tissue lyser (Retsch, ltd.) for 10 mins at the highest setting. An internal 
1
H-NMR reference 
standard TSP (δ~0ppm) was added to a final concentration of 0.1mM. Sodium azide (1% w/v) was 
added as an antimicrobial. The resulting homogenates were mixed in a 1:1 ratio with human saliva and 
allowed to ferment for 4 hours at physiological temperature (37°C) at low pH (1-3) to simulate the 
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hydrolysis conditions found in the human stomach. Following fermentation the homogenates were 
centrifuged at 10,000 g for 10 mins and the supernatant was filtered using 25mm Micropore syringe 
filters and transferred to a standard 5mm outer diameter NMR tube. The Carr-Purcell-Meiboom-Gill 
(CPMG) was applied to aqueous vegetable extracts to clearly observe the water soluble components and 
to reduce the line-broadening effect of macromolecular components and to give clear representation of 
the lower molecular weight components of interest. The CPMG sequence 
40-42
 manipulates the T2 (time 
constant for the decay of magnetization in the x-y plane perpendicular to the applied field B0) of protons 
to reduce contributions from proteins, lipids and other macromolecules. 
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Results and Discussion 
Analysis of the raw spectra showed clear differentiation of Phase II (high CV) with Phases I and III 
(low CV) by the presence of 4 singlet peaks δ2.75 (i), δ2.78 (ii), δ2.80 (iii) and δ2.83 (iv) (Figure 2A). 
Even though the diet was strictly controlled over the 42 day study duration, inter-sample differences 
were still apparent in the 
1
H-NMR urine spectra obtained for the 20 volunteers over the 3 dietary phases 
making the metabolic response to dietary intervention difficult to identify. PCA analysis of this entire 
dataset supported this observation showing the dataset was characterized by inter-sample variations 
rather than a significant variation due to the dietary interventions applied (Figure 2B). Outliers identified 
in the PCA scores plot due to poor water suppression or analytical artifact (n=13) were eliminated prior 
to subsequent modeling. Similarly, outliers due to the presence of ethanol, indicating non compliance of 
the participant with dietary protocol were also excluded (n=3). 
 
Both global and pair-wise comparison of 
1
H NMR spectra for each study phase at all collection times 
was performed using O-PLS-DA. Phases I and III, corresponding to the baseline diet and the washout 
period (both low CV) could not be separated on the basis of the metabolic profiles (Figure 2C).  
 
The O-PLS-DA coefficient plots of phase I vs. phase II and Phase II vs. Phase III urine samples 
normalised to the probability quotient indicated that the strongest discriminatory signals for CV 
intervention were the four singlet peaks identified in the raw spectra at δ2.75 (i), δ2.78 (ii), δ2.80 (iii) 
and δ2.83 (iv) (Figure 2D). The chemical shifts of these resonances were typical of bis-allylic 
compounds. These four singlets were found by comparison of any of the phase II time-points with any of 
the phase I or phase III time-point urine samples and were highly discriminant of the high CVs period. 
These peaks, therefore, were considered statistically significant biomarkers of CV intake. The O-PLS-
DA regression coefficient plot provided evidence of lower signal intensity peaks located further up field 
of the 4 singlets in the region δ3-3.5, which were overlapped and prevented facile determination of 
splitting pattern (Figure 2D).  In order to derive further structural information for each of these candidate 
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CV biomarkers, a correlation matrix was calculated from the apex of each of the peaks i-ix using the 
STOSCY method 
34
. Each individual singlet peak showed strong correlation with all of the other singlet 
peaks identified by O-PLS-DA. The lower intensity signals in the region δ3-3.5 which were 
discriminatory in the O-PLS-DA model also showed relatively strong correlation to peaks i, ii, iii and iv, 
however the lower intensity of the peaks v-ix reduced the correlation coefficients, this was explicable 
due to peak overlap and potentially the effects of urinary components such as proteins and peptide 
fragments affecting the zero baseline values. The STOCSY coefficients representing strength of 
correlation between these signals are summarized in Table 1.  
 
Intensity of the 4 singlet peaks was measured by integration of the normalized 
1
H-NMR spectra to 
ascertain a semi-quantitative urinary excretion profile of the spectral features in Phases I, II and III. The 
four singlet peaks were exclusive to the high CV consumption phase II (Figure 3), the highest 
concentration being excreted in the U0 spot urine sample. This is entirely consistent with the termination 
of the high CV diet on the evening of the day prior to urine collection. Analysis of the intensity plots 
also revealed evidence of inter-individual differences in the excretion of the 4 singlet peaks across the 
urinary time-points (reflected in the standard deviation).  Although depleted from the first collection 
point post cessation of the CV diet, candidate biomarkers i-iv were still significantly elevated above 
baseline levels at 48 h post consumption.  
 
The structural identity of the NMR spectral features identified as diagnostic of CV consumption 
between ~δ3-3.5 was difficult to ascertain by interrogation of the standard one-dimensional spectrum. 
The splitting pattern of these spectral features was confounded by spectral overlap of metabolites in 
greater abundance within the urine. Thus a 2D 
1
H-
1
H J-Res NMR experiment was conducted to increase 
signal dispersion and provide visualisation of the underlying J-couplings of these peaks in a two 
dimensional plot.  
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The J-Res experiment confirmed that these unknown peaks in this crowded area of the spectra to be 
part of an ABX spin system due to the similarity in J-coupling between an A (δ3.10) B (δ3.27) and X 
representing a doublet of doublets further up field at (δ4.38) (Figure 4A). An ABX spin system occurs 
when two methylene protons A and B are close to a proton on a chiral centre and are said to be 
diastereoscopic and are likely to have differing chemical shifts and J-couplings. The J-coupling patterns 
does not arise due to any restricted C-C bond rotation but from an absence of any bisecting plane of 
symmetry in the methylene group. Essentially, each proton appears as a doublet of doublets as it is J-
coupled to two different protons in differing chemical environments in the chiral molecule.  However, 
the X doublet of doublets at δ4.38 was not identified in the O-PLS-DA loadings coefficient plot due to 
the proximity of this peak to that of water, resulting in its removal due to varying solvent suppression. 
Analysis of the raw NMR spectra identified this doublet of doublets at δ4.38 confirming its presence in 
the phase II urine samples. The J-Res spectrum provided J-couplings of 13.43Hz between the A and B 
of the spin system and a value of 2.87Hz between the A and X and 10.56Hz between the B and X. This 
pattern of J-couplings was shared between all three spectral features suggesting membership of all three 
spectral features to the same ABX spin system. 
 
The 2D homonuclear J-res experiment suggesting a chirally centred metabolite combined with the 
strong association of the singlet resonances δ2.83, δ2.81, δ2.78 and δ2.75 with high cruciferous 
vegetable consumption were consistent with low molecular weight sulphur or nitrogen containing 
chirally centred compounds. These unknown metabolites contained magnetically isolated functional 
groups giving rise to the singlet peaks of interest, which were likely derived from the vegetables 
themselves or a metabolite of vegetable-derived material. It is known from the literature that CVs 
ubiquitously contain a methylated cysteine sulphoxide; SMCSO
37
. The 2D J-res NMR experiment and 
the spectral region of the singlet peaks was compatible with the structure of this sulphur containing 
amino acid.  
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Two dimensional heteronuclear NMR experiments 
13
C HSQC and HMBC were used to provide 
further structural information on the tentative singlet biomarkers and ABX spin system(s) identified 
within the high CV consumption study phase (Figure 4). The 
13
C HSQC experiment provided a carbon 
shift of the carbon isotope directly bonded to proton(s) of the unknown singlet peaks and the protons of 
the ABX spin system identified in the 
1
H-NMR spectra of the urine. This was further augmented by 
acquisition of multiple bond coherence values of the spectral features using 
13
C HMBC, summarized in 
Table 2. Based on the shared HSQC 
13
C shifts of the 4 singlet peaks this suggested closely related or 
very similar compounds sharing a common origin or metabolic pathway. 
 
The variation of the HMBC values for the four singlet peaks suggests they are diagnostic of CV 
consumption and represent four separate metabolites all with a similar structure and shared metabolic 
origin. This evidence suggests that the functional group responsible for the four singlet peaks are likely 
methyl protons from an S-methyl-sulphoxide functional group, supporting the proposal that one of the 
singlet peaks was the vegetable derived product SMCSO and the other 3 singlet peaks are metabolites of 
this. The two heteronuclear HSQC and HMBC NMR experiments were repeated for an aqueous 
extraction of broccoli and compared to the human urinary spectra (Figure 4B).  
 
The presence in high concentration of the singlet of interest δ2.83 in the aqueous broccoli and Brussel 
sprouts extract and the similarity in both the directly coupled and long distance 
13
C shifts with the 
product in urine confirmed the excretion of SMCSO in human urine and a major metabolite of SMCSO; 
the most predominant urinary metabolite of which is reported to be NAc-SMCSO 
38, 43
. CVs are known 
to contain the sulphur containing phytochemical SMCSO derived from amino acid biosynthesis
46
.Within 
the plant tissues it forms 1-2% of the dry weight of many varieties of CVs and is therefore ubiquitous 
and abundant in these vegetables
47
.  
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Perturbations in the global metabolic phenotype of the study subjects provided a clear separation 
between a dietary regime high in cruciferous vegetables and a diet without cruciferous vegetable 
consumption. Application of the O-PLS-DA chemometric method to the 
1
H-NMR spectra of human 
urine samples identified four significant singlet peaks characteristic of CV consumption, which showed 
decreasing urinary concentration with time after cessation of CV consumption. Application of two-
dimensional NMR spectroscopic experiments, homonuclear J-res, HSQC and HMBC to human urine 
samples indicated a low molecular weight chiral molecule with isolated functional groups of protons 
attached to either a sulphur or nitrogen. Repetition of these experiments on aqueous extracts of CVs 
confirmed the vegetable origin of one of the biomarkers in human urine. Based on the analytical 
evidence, two of the unknown metabolites were identified as a methylated cysteine sulphoxide and its 
N-acetylated product. This is consistent with the known abundant occurrence of SMCSO in CVs
37,46,47
. 
Based on the similarity of their spectral properties, the remaining unknown singlet peaks were 
hypothesized to be metabolites of deamination of SMCSO (Figure 5). 
 
This present study confirms that urinary excretion of SMCSO and its N-acetylated mammalian 
metabolite is diagnostic of subjects consuming CV. SMCSO (also known as methiin) is reported to 
occur widely within both CVs and the allium family as a plant secondary metabolite and component of 
the sulphur containing amino acid pool
46
. The fact that alliums were restricted during the study period 
means that the compound was almost certainly obtained from the high CV diet in Phase II. SMCSO is 
found in abundance in both Brussels sprouts (~68mg/100g) and broccoli (~19.1mg/100g) and dependent 
on species and cultivar, can form between 0.05-0.86% of the dry weight
47
; it is ubiquitously present in 
vegetables of the family cruciferae
47
 as a sulphur containing amino acid.  
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Conclusions 
The bulk of research on CVs has focused upon the glucosinolates and their hydrolysis products and 
the role of SMCSO has largely been ignored, despite reports in the literature of the compound’s 
biological activity including effects on hyperlipidemia, as an antidiabetic, antimicrobial and evidence of 
anti-genotoxicity
48-51
. The level of targeted research of SMCSO as an anti-carcinogenic compound 
appears to be limited and it has not been studied as a compound of biological significance in human in 
vivo studies within the context of diet and disease.  The use and limitations of glucosinolate hydrolysis 
products as biomarkers of CV consumption has been examined thoroughly by Holst and Williamson
15
.  
These authors discuss the issues of glucosinolate hydrolysis, bioavailability, metabolism, the multitude 
and diversity of glucosinolates and their hydrolysis products derived from cruciferous vegetables and the 
difficult analytical challenges they present and conclude that better biomarkers of exposure are required.   
 
The use of SMCSO as a biomarker of CV consumption is less affected by such variables and therefore 
has potential utility in targeted epidemiological studies of diet, cancer risk, diabetes, neurological and 
cardiovascular disease and population metabonomics. It could also be used to monitor adherence to a 
proscribed diet of CVs and/or alliums in human dietary intervention studies; this would certainly be 
preferable to the use of food diaries. Moreover, the use of this NMR-directed metabolic profiling 
approach enabled the detection of four statistically correlated metabolites, whose excretion covaries with 
CV consumption. A panel of four, rather than a single candidate may provide better sensitivity as an 
indicator of CV consumption. The identification of SMCSO and its N-acetylated metabolite as urinary 
biomarkers of CV consumption provides opportunities to examine the role of CV in human health, and 
also the impetus for further study of the biological role and anti-carcinogenic potential of this plant 
secondary metabolite within humans.  
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FIGURE CAPTIONS 
Figure 1 Study protocol and the nutritional intervention strategy. 
U0: initial spot urine sample; U0-10; U10-24; U24-48 hours post spot urine sample cumulative 
collections. 
 
Figure 2  Analysis of 600 MHz
  1
H NMR human urine data from participants before (Phase I), during 
(Phase II) and after (Phase III) consumption of a high concentration cruciferous vegetable diet 
(500g/day): A) Partial 
1
H spectra at the end of high CV diet Phase II (top) and low CV diet Phase I 
(bottom) i: δ2.75; ii: δ2.78; iii: δ2.81; iv: δ2.83. B) PCA scores plot demonstrating that metabolic 
variation is dominated by inter-subject variation rather than dietary effect; C) O-PLS-DA score plot 
analysis showing discrimination of high CV (Phase II) and restricted CV consumption (Phases I and III) 
and is based on a model with good explanatory (R
2Ŷ:0.783) and predictive (Q2Ŷ:0.562) ability; D) O-
PLS-DA regression coefficient loadings plot of high CV (Phase II) vs. restricted CV (phases I and III) 
confirming the four discriminatory singlet peaks of interest identified by analysis of the raw spectra  i: 
δ2.75; ii: δ2.78; iii: δ2.81; iv: δ2.83. inset: expanded region δ3-3.5,  provides evidence of further 
discriminatory 
1
H-NMR signals at higher field with a lower discriminatory power due to peak overlap  
and lower relative intensity (v: δ3.10; vi: δ3.12; vii: δ3.15; viii: δ3.28; ix: δ3.32). The signal orientation 
indicates the higher (positive orientation) or lower (negative orientation) concentration of characteristic 
metabolites with CV consumption. The colour of the signal reflects the significance of the correlation 
with diet (red indicates highest significance and blue indicates no significance). Coefficient values for 
the peaks are as follows i: δ2.75 (R2 0.51). ii: δ2.78(R2 0.85); iii: δ2.81 (R2 0.72); iv: δ2.83 (R2 0.76).  
 
Figure 3 Average individual urinary excretion kinetics of the 4 singlet peaks associated with CV 
consumption. i: δ2.75; ii: δ2.78; iii: δ2.81; iv: δ2.83 
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Integration of the singlet peaks from the normalized spectra revealed the 
1
H-NMR spectral features were 
exclusive to the high CV consumption phase II. Values are mean and SD of the peak integrals. 
 
Figure 4 2D 
1
H-
1
H J-Res and Carbon 13 NMR experiments (400MHz).  
A. Deconvolution of the NMR spectral features identified as characteristic of CV consumption 
between δ3-3.50 provide evidence of an ABX spin system of a chiral molecule  
B. 1H-13C HSQC (upper spectra): 1H-13C HMBC (lower spectra); Left: Human Urine; Right: 
aqueous broccoli extract; 
1
H and 
13
C shifts in human urine diagnostic of CV consumption match 
those of the peak at δ2.83 in brocolli. 1H-NMR: A: δ2.83; B: δ2.81; C: δ2.78; D: δ2.75.  13C-
NMR: 1: δ40.2; 2: δ55.7; 3: 60.5; 4: 60.9; 5: 63.0.  
 
Figure 5 The human metabolism of SMCSO based on the report of Waring et. al 
39
.  
The pathways were deduced after radioactive SMCSO was administered to humans (po) and 
identification of urea and inorganic sulphate formation as the primary route of excretion (~50%), 
followed by N-acetylation (~30%), unmetabolised excretion (~12%) and finally by deamination (~8%).  
Products in solid-boxes were detected in human urine in the present study by 
1
H-NMR spectroscopy. 
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TABLES 
Table 1.  Pearson correlation coefficient values for the covariant 
1
H-NMR spectral features identified by 
O-PLS-DA and STOCSY.  
Pearson correlation coefficients (R) of covarying peaks identified by STOCSY 
Covariant peaks 
2.75 
(i) 
2.81 
(ii) 
2.78 
(iii) 
2.83 
(iv) 
*3.10 
(v) 
*3.12 
(vi) 
*3.15 
(vii) 
*3.28 
(viii) 
*3.32 
(ix) 
2.75 (i) 1 0.673 0.735 0.683 0.531 0.131 0.431 0.446 0.506 
2.81 (ii) 0.673 1 0.898 0.954 0.535 0.128 0.369 0.517 0.456 
2.78 (iii) 0.735 0.898 1 0.932 0.630 0.112 0.426 0.461 0.457 
2.83 (iv) 0.683 0.954 0.932 1 0.536 0.064 0.330 0.500 0.457 
*3.10 (v) 0.531 0.535 0.630 0.536 1 0.411 0.481 0.644 0.630 
*3.12 (vi) 0.131 0.128 0.112 0.064 0.411 1 0.416 0.338 0.300 
*3.15 (vii) 0.431 0.369 0.426 0.330 0.481 0.416 1 0.299 0.257 
*3.28 (viii) 0.446 0.517 0.461 0.500 0.644 0.338 0.299 1 0.827 
*3.32 (ix) 0.506 0.456 0.457 0.457 0.630 0.300 0.257 0.827 1 
*reduced correlation coefficients for lower intensity spectral peaks are methodologically explicable by 
spectral overlapping and zero baseline effects potentially caused by urinary proteins and peptides 
fragments.  
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Table 2. Summary of 
13
C shifts for both the HSQC and HMBC experiments.   
1
H-NMR unknowns O-PLS-DA 
1
H-NMR 
(δ PPM) 
splitting 
pattern 
HSQC 
(δ13C)  
HMBC 
(δ 13C)  
2.83 singlet 40.7 55.7 
2.81 singlet 40.1 60.5 
2.78 singlet 40.2 61.1 
2.75 singlet 39.6 63.1 
3.32 ABX 60.5 39.5; 
57.1 
3.28 ABX 62.1 40.2; 
69.6 
3.1 ABX 61.7 69.2; 
180.1 
3.12 ABX 47.8 55.1 
3.15 ABX 44.4 59.8 
4.38 doublet of 
doublets 
69.1 180.7 
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SYNOPSIS TOC 
 
1
H-NMR spectroscopy combined with multivariate statistical modeling successfully identified 4 singlet 
spectroscopic peaks found to discriminate a 14 day high cruciferous vegetable (CV) consumption period 
(500g/day) from 14 day restricted CV dietary interventions in urine samples from 20 healthy Caucasian 
males, two of which were identified as S-methyl-L-cysteine sulphoxide and N-acetyl-S-methyl-L-
cysteine sulphoxide. These stable urinary biomarkers of CV consumption will facilitate future 
assessment of CV in population screening and dietary intervention studies.  
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